---
title: "Biogen Inc. Stock Underperforms Wednesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292114371.md"
description: "Biogen Inc. (BIIB) shares fell 2.60% to $200.36 on Wednesday, underperforming competitors like Johnson & Johnson and Pfizer during a broader market decline. This marks the third consecutive day of losses for Biogen, which is now trading 8.81% below its 52-week high. Trading volume reached 1.9 million, exceeding the 50-day average."
datetime: "2026-07-08T20:55:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292114371.md)
  - [en](https://longbridge.com/en/news/292114371.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292114371.md)
---

# Biogen Inc. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Biogen Inc. (BIIB) slid 2.60% to $200.36 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.28% to 7,482.71 and Dow Jones Industrial Average falling 1.09% to 52,348.39.

This was the stock's third consecutive day of losses.

Biogen Inc. closed 8.81% below its 52-week high of $219.72, which the company reached on June 29th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 1.44% to $263.40, Pfizer Inc. (PFE) fell 0.08% to $24.05, and AbbVie Inc. (ABBV) fell 0.75% to $252.74.

Trading volume (1.9 M) eclipsed its 50-day average volume of 1.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 8, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-08-26 1655ET

### Related Stocks

- [BIIB.US](https://longbridge.com/en/quote/BIIB.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [KBC Group NV Raises Stock Position in Biogen Inc. $BIIB](https://longbridge.com/en/news/293318298.md)
- [Bank of New York Mellon Corp Lowers Stock Position in Biogen Inc. $BIIB](https://longbridge.com/en/news/293175480.md)
- [Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.](https://longbridge.com/en/news/291698245.md)
- [Why Is Biogen Stock Falling Tuesday?](https://longbridge.com/en/news/292652224.md)
- [Stryker (SYK) Could Be 15% Below Fair Value As Mako RPS Launch Draws Focus](https://longbridge.com/en/news/293831896.md)